Corium's Novel ADHD Medication AZSTARYS® (Serdexmethylphenidate and Dexmethylphenidate) Had No Clinically Significant Impact on Children's Weight and Height Growth Rate
/PRNewswire/ -- Corium, LLC, a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS)...
United States Ann Childress Adolesc Psychopharmacol Us Centers For Disease Prnewswire Corium Adolescent Psychopharmacology
Source: prnewswire.com